chr2-178757628-G-C
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_001267550.2(TTN):c.10592C>G(p.Ser3531*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000186 in 1,613,582 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001267550.2 stop_gained
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| TTN | NM_001267550.2 | c.10592C>G | p.Ser3531* | stop_gained | Exon 45 of 363 | ENST00000589042.5 | NP_001254479.2 | |
| TTN | NM_133379.5 | c.10303+1356C>G | intron_variant | Intron 44 of 45 | ENST00000360870.10 | NP_596870.2 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| TTN | ENST00000589042.5 | c.10592C>G | p.Ser3531* | stop_gained | Exon 45 of 363 | 5 | NM_001267550.2 | ENSP00000467141.1 | ||
| TTN | ENST00000360870.10 | c.10303+1356C>G | intron_variant | Intron 44 of 45 | 5 | NM_133379.5 | ENSP00000354117.4 | 
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152140Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.00000402  AC: 1AN: 248590 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  6.84e-7  AC: 1AN: 1461442Hom.:  0  Cov.: 31 AF XY:  0.00  AC XY: 0AN XY: 727002 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152140Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 74324 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2J;C1858763:Dilated cardiomyopathy 1G    Uncertain:1 
This sequence change creates a premature translational stop signal (p.Ser3531*) in the TTN gene. While this is not anticipated to result in nonsense mediated decay, it is expected to create a truncated TTN protein. This variant is present in population databases (rs767420661, gnomAD 0.007%). This premature translational stop signal has been observed in individual(s) with dilated cardiomyopathy (PMID: 25589632). ClinVar contains an entry for this variant (Variation ID: 223345). This variant is located in the I band of TTN (PMID: 25589632). Truncating variants in this region have been shown to be highly prevalent in the general population and unaffected individuals (PMID: 26701604, 22335739). However, truncating variants in this region have also been reported in individuals affected with autosomal recessive centronuclear myopathy (PMID: 23975875). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not provided    Uncertain:1 
Reported in an individual with dilated cardiomyopathy, however, detailed clinical and segregation information were not included (Roberts et al., 2015); Not observed at a significant frequency in large population cohorts (Lek et al., 2016); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in the I-band region of the TTN gene, which is not one of the regions known to be significantly associated with TTN-related disease; Present in an alternate meta-transcript which contains all possible coding exons of the TTN gene (NM_001267550.1), and is not present in the coding portion of the TTN primary transcripts (NM_133378.4 and NM_001256850.1); This variant is associated with the following publications: (PMID: 25589632) -
Primary dilated cardiomyopathy    Uncertain:1 
This TTN truncating variant (TTNtv) was identified in one individual in this cohort and is located in an exon with low levels of cardiac expression. In the seven cohorts assessed, TTNtv were found in 14% of ambulant DCM, 22% end-stage or familial DCM, and 2% controls. Heterozygous nonsense, frameshift and canonical splice-disrupting variants found in constitutive and other highly utilised exons are highly likely to be pathogenic when identified in individuals with phenotypically confirmed DCM. TTNtv found incidentally in healthy individuals (excluding familial assessment of DCM relatives) are thought to have low penetrance, particularly when identified in exons that are not constitutively expressed in the heart. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at